Resources for you and your patients
Page contents
Practicalities
SC Checklist beginning of treatment
Includes a first use checklist of Darzalex® SC.
Darzalex® SC Practical Guide
Includes DARZALEX® SC handling and administration info, pre and post-injection medications, and more
Study profiles
CASSIOPEIA study
Summary of study design, efficacy results and safety profile for DVTd in transplant-eligible NDMM.
MAIA study
Summary of study design, efficacy results and safety profile for DRd in transplant-ineligible NDMM.
ALCYONE study
Summary of study design, efficacy results and safety profile for DVMP in transplant-ineligible NDMM.
Dosing schedules
Dosing schedules for all Darzalex® treatment regimens
Patient support materials
Resources to support your patients
My Care is a project that aims to support healthcare professionals and patients throughout their journey.
Glossary
JMC: Janssen Medical Cloud
MRD: minimal residue disease
PFS: progression-free disease
QOL: quality of life
Titular da Autorização de Introdução no Mercado: Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Bélgica.
Para mais informações deverá contactar o Representante do Titular da Autorização de Introdução no Mercado: Janssen-Cilag Farmacêutica, Lda.
Medicamento de receita médica restrita, de utilização reservada a certos meios especializados.
Antes de prescrever consulte o RCM completo.
RCM de Darzalex®, veja aqui